Complex interactions in Parkinson's disease: a two-phased approach
- PMID: 12784265
- DOI: 10.1002/mds.10431
Complex interactions in Parkinson's disease: a two-phased approach
Abstract
The identification of pathogenic mutations in the three genes alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 (UCHL1) has elucidated the ubiquitin proteasome system (UPS) and its potential role as a causal pathway in Parkinson's disease (PD). In addition, polymorphisms of these three genes have been shown to be independently associated with PD. In a sample of 298 unrelated PD cases and 185 controls, we applied a two-phased approach of recursive partitioning and logistic regression analyses to explore complex interactions. For women only, we observed an epistatic interaction of UCHL1 and alpha-synuclein genotypes with significant effects on PD risk (odds ratio = 2.42; P = 0.003). Our findings are consistent with the hypothesis that PD is a multigenic disorder of the UPS.
Copyright 2003 Movement Disorder Society
Similar articles
-
Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.Ann Neurol. 2000 Feb;47(2):201-10. Ann Neurol. 2000. PMID: 10665491
-
The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects.Ann N Y Acad Sci. 2003 Jun;991:80-92. doi: 10.1111/j.1749-6632.2003.tb07465.x. Ann N Y Acad Sci. 2003. PMID: 12846976 Review.
-
Genetics of Parkinson's disease.Ann N Y Acad Sci. 2000;920:28-32. doi: 10.1111/j.1749-6632.2000.tb06901.x. Ann N Y Acad Sci. 2000. PMID: 11193165 Review.
-
Genetics of Parkinson's disease.J Neurol. 2001 Oct;248(10):833-40. doi: 10.1007/s004150170066. J Neurol. 2001. PMID: 11697518 Review.
-
Parkinson's disease: one biochemical pathway to fit all genes?Trends Mol Med. 2002 May;8(5):236-40. doi: 10.1016/s1471-4914(02)02333-x. Trends Mol Med. 2002. PMID: 12067634 Review.
Cited by
-
Common variants in PARK loci and related genes and Parkinson's disease.Mov Disord. 2011 Feb 1;26(2):280-8. doi: 10.1002/mds.23376. Epub 2010 Dec 13. Mov Disord. 2011. PMID: 21412835 Free PMC article.
-
Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model.J Proteome Res. 2010 Mar 5;9(3):1496-509. doi: 10.1021/pr901024z. J Proteome Res. 2010. PMID: 20155936 Free PMC article.
-
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4635-40. doi: 10.1073/pnas.0806474106. Epub 2009 Mar 4. Proc Natl Acad Sci U S A. 2009. PMID: 19261853 Free PMC article.
-
Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis.Am J Epidemiol. 2009 Dec 1;170(11):1344-57. doi: 10.1093/aje/kwp288. Epub 2009 Oct 28. Am J Epidemiol. 2009. PMID: 19864305 Free PMC article. Review.
-
Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age.Neurol Sci. 2015 Feb;36(2):179-88. doi: 10.1007/s10072-014-1987-y. Epub 2014 Nov 6. Neurol Sci. 2015. PMID: 25370916 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous